Author

Lauren Hoorens Van Heyningen

Observed name: Lauren Hoorens van Heyningen

Institution: Boston Children's Hospital

Observed institutions: Boston Children's Hospital, Utrecht University, University Medical Center Utrecht, University of Maryland, College Park

ORCID: 0000-0002-6025-3398

Observed ORCID: 0000-0002-6025-3398

OpenAlex ID: A5064200798

Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D‐Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity

2023 · Stephanie M. Kronstadt, Divya B. Patel, et al. · Advanced Healthcare Materials · 75

Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

2023 · Patricia Hernández-López, Eline van Diest, et al. · Nature Immunology · 24

Assessment of anti-inflammatory bioactivity of extracellular vesicles is susceptible to error via media component contamination

2022 · Stephanie M. Kronstadt, Lauren Hoorens Van Heyningen, et al. · Cytotherapy · 19

Sensitivity to Vγ9Vδ2TCR T cells is imprinted after single mutations during early oncogenesis

2024 · Astrid Cleven, Angelo D. Meringa, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4

Nanobodies specific for Vβ11 enable detection and noninvasive imaging of antigen-specific T cells in vivo

2026 · Stephanie D Scharmann, Francisca Faber, et al. · The Journal of Immunology

Targeting the Idiotype: Nanobody-Based PET Imaging of Antigen-Specific T Cells in Experimental Autoimmune Encephalomyelitis 2260726

2026 · Stephanie Scharmann, Francisca Faber, et al. · The Journal of Immunology

Works count: 6

Citation count: 122

H-index: 4

I10-index: 3